Previous Close | 26.81 |
Open | 26.65 |
Bid | 25.89 x 200 |
Ask | 25.98 x 100 |
Day's Range | 25.78 - 26.77 |
52 Week Range | 25.74 - 48.60 |
Volume | |
Avg. Volume | 502,475 |
Market Cap | 1.205B |
Beta (5Y Monthly) | 0.75 |
PE Ratio (TTM) | 29.10 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
The truth is that if you invest for long enough, you're going to end up with some losing stocks. But the long term...
In this article, we will take a look at aggressive stock portfolio: 13 stocks picked by analysts. To skip our analysis of the recent market activity, you can go directly to see the Aggressive Stock Portfolio: 5 Stocks Picked by Analysts. By definition, aggressive stocks are ones that offer higher returns than conservative and relatively […]
Pacira (PCRX) receives the FDA's RMAT designation for its gene-therapy product candidate, PCRX-201, which is currently being developed in an early-stage study to treat osteoarthritis of the knee.